Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1980 Jun;312(2):117-21.
doi: 10.1007/BF00569719.

Effects of McN-A-343, a cholinomimetic drug, on endplate currents in the frog

Effects of McN-A-343, a cholinomimetic drug, on endplate currents in the frog

K Alkadhi et al. Naunyn Schmiedebergs Arch Pharmacol. 1980 Jun.

Abstract

The muscarinic ganglion stimulating agent, McN-A-343 has unusual blocking actions on endplate currents (EPCs) at frog neuromuscular junctions. McN-A-343 caused depolarization by a curare-sensitive process, blocked neuromuscular transmission, depressed EPCs and reduced the time for EPC decay. These results are explained best by a nicotinic agonist action of McN-A-343 on the acetylcholine receptor to cause ion flow and the blockade by McN-A-343 of the open ion channels. The actions of McN-A-343 are similar to those of decamethonium (C-10) described by others. Unlike C-10, however, McN-A-343 did not alter the exponential character of the EPC or alter the voltage dependency of the EPC. The prototypical nicotinic agonist, dimethylphenylpiperazinium had no effect on EPC parameters of endplate clamped at -90mV.

PubMed Disclaimer

Similar articles

References

    1. J Pharmacol Exp Ther. 1961 May;132:156-70 - PubMed
    1. J Pharmacol Exp Ther. 1971 Feb;176(2):423-33 - PubMed
    1. J Pharmacol Exp Ther. 1972 Sep;182(3):427-41 - PubMed
    1. Br J Pharmacol. 1976 Jan;56(1):111-3 - PubMed
    1. Proc R Soc Lond B Biol Sci. 1978 Dec 4;203(1151):119-33 - PubMed

Publication types

MeSH terms

Substances